This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Brighter Valuation

Is BRIG undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of BRIG when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate BRIG's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate BRIG's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for BRIG?

Key metric: As BRIG is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for BRIG. This is calculated by dividing BRIG's market cap by their current revenue.
What is BRIG's PS Ratio?
PS Ratio	0.7x
Sales	SEK 33.03m
Market Cap	SEK 23.21m

BRIG key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.4x
Enterprise Value/EBITDA	-0.1x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does BRIG's PS Ratio compare to its peers?

The above table shows the PS ratio for BRIG vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	5.2x
CRBX Carbiotix	10.6x	n/a	SEK 34.6m
MEDF Medfield Diagnostics	3.3x	n/a	SEK 23.6m
ZENI Zenicor Medical Systems	0.8x	n/a	SEK 26.9m
FLUI Fluicell	5.9x	n/a	SEK 28.4m
BRIG Brighter	0.7x	n/a	SEK 23.2m

Price-To-Sales vs Peers: BRIG is good value based on its Price-To-Sales Ratio (0.7x) compared to the peer average (8.9x).

Price to Sales Ratio vs Industry

How does BRIG's PS Ratio compare vs other companies in the SE Medical Equipment Industry?

12 Companies	Price / Sales	Estimated Growth	Market Cap
Industry Avg.	4.7x	17.5%
BRIG Brighter	0.7x	n/a	US$2.23m
ARJO B Arjo	0.8x	3.7%	US$844.23m
CARE Careium	0.8x	10.2%	US$64.16m

12 Companies		Estimated Growth	Market Cap
Industry Avg.	4.7x	37.0%
BRIG Brighter	0.7x	n/a	US$2.23m

No more companies

Price-To-Sales vs Industry: BRIG is good value based on its Price-To-Sales Ratio (0.7x) compared to the Swedish Medical Equipment industry average (8.7x)

Price to Sales Ratio vs Fair Ratio

What is BRIG's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

BRIG PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.7x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate BRIG's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Iconovo

SEK 80.5m

Develops and licenses inhalation medications in Sweden.

ICO

SEK 5.06

-0.8%

-45.4%

Dignitana

SEK 99.1m

A medical technology company, engages in the development, production, and marketing of medical cooling devices in the United States and internationally.

DIGN

SEK 1.23

11.8%

-42.8%

Mentice

SEK 583.0m

Provides endovascular simulation technology solutions in Europe, the Middle East, Africa, Asia, the Asia Pacific region, and the Americas.

MNTC

SEK 22.80

8.6%

-44.7%